Dr Kauffman has enjoyed a long and successful career in the pharmaceutical industry, where he continues to play a key role in developing life-saving drugs. His current work with Karyopharm involves developing novel oral anti-cancer drugs for multiple tumours. Its first product, selinexor, is in late-stage clinical testing in blood cancers.